Eric Lefkofsky Uses Tempus to Produce Molecular Data for Breast Cancer Treatment

EricLefkofsky is the founder of Tempus, a company that works round the clock to provide physicians with relevant and updated information on cancer treatment, therapies and advanced technology. Recently, Lefkofsky announced his interest in assisting the Chicago University of Medicine with fighting breast cancer. The announcement came in at a crucial time when the University of Chicago had a drawback due to limited data provided to the physicians.

Partnership

The entry of Tempus in the field would aid in the provision of molecular and sequencing data for breast cancer analysis and treatment. The partnership would also help with personalizing breast cancer treatment in patients. Tempus stated that it would analyze all data from approximately 1,000 patients who have breast cancer. The research will assist in determining the right treatment for patients. With this research, it will be easy for physicians and researchers to explore patterns that can help in predicting the response of patients in treatment. The objective of the partnership is coming up with important data reports to help in providing treatment.

Contribution

While giving a speech of appreciation, Dr. Olufunmilayo Olopade of the University of Chicago said that although breast cancer tops the list of the most aggressive cancers in the world, there is little accessible data for the millions of patients. Olufunmilayo also said that the limited information provided on breast cancer is not enough to provide definitive treatments. The limiting information also leads physicians to make decisions on treatment without highly specified genetic information. This information always helps in coming up with better-targeted treatment solutions. Dr. Olufunmilayo said that his team was elated to be in partnership with Tempus and Eric on Facebook.

Tempus

Tempus employs technology for genomic sequencing. This is done to help physicians make wise and valid treatment decisions. The objective of Tempus is coming up with personalized treatment solutions for patients. The company was established in 2015. It is headquartered in Chicago and more information click here.

Eric’s Profile

Eric Lefkofsky is an executive entrepreneur. He is the founder of Tempus Start-up. He has invested in businesses, and Groupon is one of them. Tempus is his current success story. The company uses technology to come up with patients’ personalized treatment.

More visit: https://twitter.com/lefkofsky